Have Your Company Be a Newsmaker at DCAT Week

Does your company have major company news that it would like to share at DCAT Week? DCAT Member Companies are invited to apply to present at the Member Company Announcement Forum, a valuable platform in which senior executives make significant news announcements.

Does your company have major company news that it would like to share at DCAT Week? DCAT Member Companies are invited to apply to present at the Member Company Announcement Forum, a valuable platform in which senior executives make significant news announcements.

Hear from senior executives on major company news
The DCAT Member Company Announcement Forum is a much-anticipated program at DCAT Week in which senior executives from DCAT Member Companies make major news announcements to DCAT Week’s influential attendees and the industry press.

Exclusive to DCAT Member Companies, the DCAT Member Company Announcement Forum is a valuable platform to highlight key news developments from your company occurring in 2026* in the following areas:

  • Mergers and acquisitions (M&A), including post-M&A integration;
  • Significant and critical capital expansions for manufacturing and development capacity across the bio/pharmaceutical manufacturing value chain—raw materials, chemicals, processing aids, excipients, and other inputs; drug substances (small molecules & biologics); drug products; and packaging; and
  • Other key corporate strategic developments occurring in 2025 and beyond.

*Note: News announcements must be from January 2026 forward. If an announcement was first made prior to January 2026, updated information occurring in 2026 or beyond must be included. In the case of M&A, this can include deal closing or post-M&A integration occurring in 2026 or beyond, and for expansions, updated timelines for completion and launch occurring in 2026 or beyond.

Who Can Apply & Deadlines
The Member Company Announcement Forum is open to all Registered DCAT Member Companies: bio/pharma companies, CDMOs/CMOs, and other suppliers—large, mid-sized, and small companies. Applications are due Monday February 2, 2026. Further information, including the online applications, may be found here

Applications are reviewed by the DCAT Member Company Announcement Forum Oversight Committee, which selects those companies receiving podium time at DCAT Week based on the following criteria: news priority, criticality of the news development, and interest to DCAT Member Companies.

Where & When
The Member Company Announcement Forum will be held during DCAT Week on Monday March 23, 2026 (9:00-11:30 AM) at the InterContinental New York Barclay, Grand Ballroom (2nd Floor). The program is complimentary and exclusive to DCAT Member Companies. To register to attend, click here

Recent Feature Articles

CDMO Insights: What’s Trending in the Injectable Drug Market?

By
GPL-1s for treating Type 2 diabetes and obesity have been a key growth driver for the bio/pharma industry as well as for CDMOs of injectables, but will the entry of oral GLP-1s and related drugs put a damper on growth prospects for injectables? What is the expected market penetration?

Pharma Customer–Supplier Insights: What Constitutes Value Creation?

By
Delivering value beyond product and price is crucial for CDMOs and suppliers to gain a competitive edge with their bio/pharma customers, but are the buy and sell side aligned in what constitutes value? The latest DCAT Benchmarking & Research study provides key insights.

Small-Molecule CDMO Outlook: What Lies Ahead

By
At the mid-point in 2026, how are small-molecule CDMOs faring? Larger CDMOs are faring well while CDMOs in early-stage capabilities face some headwinds with more challenging biotech financing

Biotech IPOs: Who Is Topping the Class of 2026?

By
What companies are topping biotech IPOs in 2026? Parabilis Medicines with a focus on alpha-helical peptides and Kailera Therapeutics specializing in GLP-1s and related drugs for obesity are leading the way. By Patricia Van…